(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-20.00% $ 0.00400
Live Chart Being Loaded With Signals
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide...
Stats | |
---|---|
Volumen de hoy | 1.14M |
Volumen promedio | 3.26M |
Capitalización de mercado | 14.81M |
EPS | $0 ( 2024-02-25 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-15 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.400 |
ATR14 | $0 (0.00%) |
Oncosil Medical Ltd Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Oncosil Medical Ltd Finanzas
Annual | 2023 |
Ingresos: | $367 677 |
Beneficio Bruto: | $-6.49M (-1 766.30 %) |
EPS: | $-0.00950 |
FY | 2023 |
Ingresos: | $367 677 |
Beneficio Bruto: | $-6.49M (-1 766.30 %) |
EPS: | $-0.00950 |
FY | 2022 |
Ingresos: | $231 789 |
Beneficio Bruto: | $-6.73M (-2 902.18 %) |
EPS: | $-0.0102 |
FY | 2021 |
Ingresos: | $213 070 |
Beneficio Bruto: | $-747 953 (-351.04 %) |
EPS: | $-0.0159 |
Financial Reports:
No articles found.
Oncosil Medical Ltd
OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico